Our Story: Started By A Patient For Patients
Born with a rare genetic eye disease called Stargardt’s, Founder Bryan Manning knows the importance of giving patients what they deserve: access to potentially life-changing scientific discoveries. Upon learning that a clinical trial that could have cured his retinal condition failed because it could not find enough patients, Manning found that roadblock unacceptable — and entirely avoidable. He became resolute in his mission to never allow a trial to fail due to under-enrollment, and turned to his team of best-in-class content creators from Two Blind Brothers, one the fastest growing cause-based companies in the country, which he co-founded.
In the years since, the Clinical Enrollment team has altered the landscape of clinical trial recruitment by expertly leveraging the greatest patient outreach tool ever created: social media. CE’s drug sponsor clients, who include some of the biggest names in biotech, consistently meet or exceed drug milestones and maintain robust participant pools, even when contracted more than ⅔ of the way through the trial process when recruitment numbers typically stall. Their commitment to recruiting diverse candidate populations at unprecedented rates and upholding the most rigorous patient screening standards complements CE’s nuanced targeting approach, which prioritizes storytelling and emotion-driven messaging. Since its inception, Clinical Enrollment has demonstrated an innate understanding of this humanity-meets-analytics model, and it is this success — along with changing the lives of patients like Manning — that matters most.
The Clinical Enrollment patient quality approach
Get Started
Need highly-targeted clinical trial participants? Let’s work together.